LON:SENS Sensyne Health (SENS) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Sensyne Health Stock (LON:SENS) Get Sensyne Health alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume4.45 million shsAverage Volume3.45 million shsMarket Capitalization£583 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care's ‘Initial Code of Conduct for data-driven health and care technology'. Read More Receive SENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensyne Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SENS Stock News HeadlinesLeading Artificial Intelligence (AI) Companies in Clinical TrialsSeptember 24, 2024 | finance.yahoo.comBig Pharma is forging an increased number of partnerships with artificial intelligence vendors for drug discovery servicesJuly 22, 2024 | finance.yahoo.comBill Gates said this would never work. Then he wrote a $100M check.Bill Gates spent a decade insisting this energy source couldn't supply more than 5% of global power. Then he toured a construction site in the Nevada desert and told Bloomberg he now believes it could reach 20%. He followed that reversal with a $100 million investment. Facebook's co-founder added $462 million. Tesla's co-founder and Norway's sovereign wealth fund also took positions. One company - 60 years of operating history, revenue approaching $1 billion - sits at the center of all of it, with a July 4th catalyst that locks in its competitive advantage for eight years. | Behind the Markets (Ad)Best Collagen Powders Of 2024, According To ExpertsMarch 9, 2024 | forbes.comNHS data sale 'an invasion of privacy', campaigners sayDecember 8, 2023 | bbc.comBAre Health Insurance Premiums Tax-Deductible?August 2, 2023 | investopedia.comBMI Calculator: Check Your Body Mass IndexJune 8, 2023 | forbes.comFind The Right Health Insurance For YouMay 27, 2023 | forbes.comSee More Headlines SENS Stock Analysis - Frequently Asked Questions How do I buy shares of Sensyne Health? Shares of SENS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Sensyne Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sensyne Health investors own include BP (BP), Industry, Sector and Symbol Stock ExchangeLON SectorComputer and Technology Industry Health Information Services Sub-IndustryN/A Current SymbolLON:SENS CIKN/A Webwww.sensynehealth.com Phone44 3300 581845FaxN/AEmployees70Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio6.02 Current Ratio2.26 Quick Ratio2.26 Sales & Book Value Annual Sales£7.81 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.07 Book ValueGBX 20.30 per share Price / BookN/AMiscellaneous Outstanding Shares166,464,000Free FloatN/AMarket Cap£583 thousand OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (LON:SENS) was last updated on 6/24/2026 by MarketBeat.com Staff. From Our PartnersMy feud with Zohran MamdaniNearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...Stansberry Research | SponsoredQuick favor to ask youBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTop Banks Warn: A Strange Day is Coming to AmericaGoldman Sachs and Morgan Stanley are warning clients about a developing crisis that could suppress portfolio g...TradeSmith | SponsoredA drilling crew just broke a record nobody expectedA drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of E...Behind the Markets | SponsoredRead this before you touch SPCXSPCX is live on Nasdaq - but a market expert who called AMD before it climbed as high as 7,100% says buying th...Altimetry | SponsoredMillionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...Brownstone Research | SponsoredKarp just filed Form 144On May 12, 2026, Palantir CEO Alex Karp filed to sell 585,000 shares - roughly $95.93 million. Combined with f...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensyne Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensyne Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.